A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy

By K. J. Zee, Donna-Marie Manasseh, J. Bevilacqua, S. Boolbol, J. Fey, L. Tan, P. Borgen, H. Cody, M. Kattan. Annals of Surgical Oncology, 2003

825 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. (2005, methodology): “This nomogram was then prospectively validated on a subsequent population of 373 patients.(53) Micrometastases and isolated tumor cells.”
A Mathematical Model for Interpretable Clinical Decision Support with Applications in Gynecology (2012, methodology): “Kattan [10] proposed the use of nomograms [11–19] as a paper-based CDS system.”
Locoregional Recurrence after Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial (2010, background): “Several nomograms have incorporated these prognostic features to predict the probability of involved nonSNs.(20,21) Proponents of the use of such nomograms postulate that axillary dissection should be necessary only if there are likely additional involved lymph nodes.”